Buprenorphine/Naloxone

@article{Orman2012BuprenorphineNaloxone,
  title={Buprenorphine/Naloxone},
  author={Jennifer S. Orman and G. Keating},
  journal={Drugs},
  year={2012},
  volume={69},
  pages={577-607}
}
  • Jennifer S. Orman, G. Keating
  • Published 2012
  • Medicine
  • Drugs
    • SummaryAbstractBuprenorphine/naloxone (Suboxone®) comprises the partial μ-opioid receptor agonist buprenorphine in combination with the opioid antagonist naloxone in a 4: 1 ratio. When buprenorphine/naloxone is taken sublingually as prescribed, the naloxone exerts no clinically significant effect, leaving the opioid agonist effects of buprenorphine to predominate. However, when buprenorphine/naloxone is parenterally administered in patients physically dependent on full agonist opioids, the… CONTINUE READING
    View on Springer
    addictiondomain.com
    67 Citations
    Highly Influencial Citations
    2
    Background Citations
    20
    Methods Citations
    2
    Results Citations
    1
    67 Citations
    Citation Type

    Citation Type

    Buprenorphine/Naloxone (Zubsolv®): A Review in Opioid Dependence
    Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial.
    • 10
    Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
    • PDF
    Urine naloxone concentration at different phases of buprenorphine maintenance treatment.
    • 17
    Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial.
    • 14
    • PDF
    Patients that benefit from buprenorphine-naloxone on medically assisted treatment for opioid dependence in Malaysia.
    • Highly Influenced
    • PDF
    Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals
    • 10
    Concomitant drugs with buprenorphine user deaths.
    Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation
    • 54
    Buprenorphine analogue BU08028 is one step closer to the Holy Grail of opioid research
    • J. Li
    • Medicine
    • Proceedings of the National Academy of Sciences
    • 2016
    • 4
    • PDF

    References

    SHOWING 1-10 OF 106 REFERENCES
    Effects of buprenorphine/naloxone in opioid-dependent humans
    • 155
    Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine
    • 48
    Buprenorphine and naloxone interactions in methadone maintenance patients
    • 51
    Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers
    • 69
    • PDF
    Buprenorphine-Containing Treatments
    • 13
    Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
    • 108
    • PDF
    Buprenorphine: how to use it right.
    • 198
    Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    • 77
    Effects of buprenorphine and methadone in methadone-maintained subjects
    • 89
    Buprenorphine and naloxone alone and in combination in opioid-dependent humans
    • 57
    • PDF